Yantai Dongcheng Biochemicals (002675.SZ) plans to repurchase company shares worth 100 million to 200 million yuan.

17:16 04/01/2026

Dongcheng Pharmaceutical (002675.SZ) announced that the company plans to repurchase some of its publicly held shares through centralized bidding trading using its own funds or self-raised funds, for the purpose of implementing employee shareholding plans and/or equity incentive plans. The amount of repurchased shares shall not be less than RMB 100 million (inclusive) and shall not exceed RMB 200 million (inclusive), with a repurchase price not exceeding RMB 18.00 per share (inclusive).

Yantai Dongcheng Biochemicals (002675.SZ) announced that the company plans to repurchase a portion of its publicly traded shares through centralized competitive trading using company funds or self-raised funds, for the purpose of implementing an employee shareholding plan and/or equity incentive plan. The amount of repurchased shares will not be less than RMB 100 million, and not more than RMB 200 million, with a repurchase price not exceeding RMB 18.00 per share.

Macau Gaming Holdings (00880) plans to acquire $500 million in cash for the preferential notes maturing in 2026, and simultaneously promote the issuance of new notes.

COLOUR LIFE (01778) plans to conduct a stock restructuring. The stake held by Huayuan Nian will decrease to approximately 9.98%.

SJM Holdings (00880) is planning to issue U.S. dollar-denominated preferred notes.

Macau Gaming Holdings (00880) plans to acquire $500 million in cash for the preferential notes maturing in 2026, and simultaneously promote the issuance of new notes.

COLOUR LIFE (01778) plans to conduct a stock restructuring. The stake held by Huayuan Nian will decrease to approximately 9.98%.

SJM Holdings (00880) is planning to issue U.S. dollar-denominated preferred notes.